Skip to main content
Erschienen in: General Thoracic and Cardiovascular Surgery 5/2023

12.01.2023 | Review Article

Improving survival after pulmonary metastasectomy for sarcoma: analysis of prognostic factors

verfasst von: Daniel Shell

Erschienen in: General Thoracic and Cardiovascular Surgery | Ausgabe 5/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Metastatic sarcoma confers a grave prognosis to patients and poses a management dilemma for clinicians. Pulmonary metastasectomy is frequently performed for the recurrence of sarcomatous tumours in the lung, but the evidence-base is poor. No guidelines exist to inform clinicians on appropriate patient selection and surgical technique.

Aim

This review aims to establish and analyse the most important prognostic factors for survival post pulmonary metastasectomy for recurrent sarcoma. We summarise the key tumour, peri-operative and patient characteristics that should guide surgical management.

Methods

A comprehensive search of the literature utilising OVID Medline and PubMed databases was conducted to identify all relevant research within the past 15 years. We evaluated all articles that specifically studied sarcoma patients (both bone and soft tissue).

Conclusion

Disease-free interval and tumour burden remain important prognostic factors, while tumour grade is likely not significant. VATS is a safe and viable alternative to thoracotomy without sacrificing survival outcomes. No single peri-operative characteristic provides useful prognostic information in isolation.
Literatur
1.
Zurück zum Zitat Songür N, Dinç M, Ozdilekcan C, Eke S, Ok U, Oz M. Analysis of lung metastases in patients with primary extremity sarcoma. Sarcoma. 2003;7:63–7.PubMedPubMedCentralCrossRef Songür N, Dinç M, Ozdilekcan C, Eke S, Ok U, Oz M. Analysis of lung metastases in patients with primary extremity sarcoma. Sarcoma. 2003;7:63–7.PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Omura A, Kimura T, Tanaka R, Hiroshima T, Maniwa T, Takenaka S, et al. Surgical indication of pulmonary metastasis arising from osteosarcoma or soft tissue sarcoma. Gen Thorac Cardiovasc Surg. 2022;70:273–9.PubMedCrossRef Omura A, Kimura T, Tanaka R, Hiroshima T, Maniwa T, Takenaka S, et al. Surgical indication of pulmonary metastasis arising from osteosarcoma or soft tissue sarcoma. Gen Thorac Cardiovasc Surg. 2022;70:273–9.PubMedCrossRef
4.
Zurück zum Zitat Kawamoto T, Hara H, Morishita M, Fukase N, Kawakami Y, Takemori T, et al. Prognostic influence of the treatment approach for pulmonary metastasis in patients with soft tissue sarcoma. Clin Exp Metastasis. 2020;37:509–17.PubMedCrossRef Kawamoto T, Hara H, Morishita M, Fukase N, Kawakami Y, Takemori T, et al. Prognostic influence of the treatment approach for pulmonary metastasis in patients with soft tissue sarcoma. Clin Exp Metastasis. 2020;37:509–17.PubMedCrossRef
5.
Zurück zum Zitat Treasure T, Møller H, Fiorentino F, Utley M. Editorial comment: Forty years on: pulmonary metastasectomy for sarcoma. Eur J Cardiothorac Surg. 2013;43:799–800.PubMedCrossRef Treasure T, Møller H, Fiorentino F, Utley M. Editorial comment: Forty years on: pulmonary metastasectomy for sarcoma. Eur J Cardiothorac Surg. 2013;43:799–800.PubMedCrossRef
6.
Zurück zum Zitat Pastorino U, Buyse M, Friedel G, Ginsberg RJ, Girard P, Goldstraw P, et al. Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg. 1997;113:37–49.PubMedCrossRef Pastorino U, Buyse M, Friedel G, Ginsberg RJ, Girard P, Goldstraw P, et al. Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg. 1997;113:37–49.PubMedCrossRef
7.
Zurück zum Zitat Predina JD, Puc MM, Bergey MR, Sonnad SS, Kucharczuk JC, Staddon A, et al. Improved survival after pulmonary metastasectomy for soft tissue sarcoma. J Thorac Oncol. 2011;6:913–9.PubMedCrossRef Predina JD, Puc MM, Bergey MR, Sonnad SS, Kucharczuk JC, Staddon A, et al. Improved survival after pulmonary metastasectomy for soft tissue sarcoma. J Thorac Oncol. 2011;6:913–9.PubMedCrossRef
8.
Zurück zum Zitat Lee RM, Ethun CG, Gamboa AC, Turgeon MK, Tran T, Poultsides G, et al. A novel preoperative risk score to guide patient selection for resection of soft tissue sarcoma lung metastases: An analysis from the United States Sarcoma Collaborative. J Surg Oncol. 2021;124:1477–84.PubMedPubMedCentralCrossRef Lee RM, Ethun CG, Gamboa AC, Turgeon MK, Tran T, Poultsides G, et al. A novel preoperative risk score to guide patient selection for resection of soft tissue sarcoma lung metastases: An analysis from the United States Sarcoma Collaborative. J Surg Oncol. 2021;124:1477–84.PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat Özdil A, Tekneci AK, Dökümcü Z, Divarcı E, Keçeci B, Sezak M, et al. Pulmonary metastasectomy of sarcoma: is the ratio of surgical margin to nodule size a prognostic factor? Thorac Cardiovasc Surg. 2019;67:675–82.PubMedCrossRef Özdil A, Tekneci AK, Dökümcü Z, Divarcı E, Keçeci B, Sezak M, et al. Pulmonary metastasectomy of sarcoma: is the ratio of surgical margin to nodule size a prognostic factor? Thorac Cardiovasc Surg. 2019;67:675–82.PubMedCrossRef
10.
Zurück zum Zitat Ahn Y, Lee SM, Kim MS, Choi S, Kim S, Do K-H, et al. Volume doubling times of pulmonary metastases in patients with bone and soft-tissue sarcomas: associations with subsequent new metastases and survival after metastasectomy. Am J Roentgenol. 2022;218:624–32.CrossRef Ahn Y, Lee SM, Kim MS, Choi S, Kim S, Do K-H, et al. Volume doubling times of pulmonary metastases in patients with bone and soft-tissue sarcomas: associations with subsequent new metastases and survival after metastasectomy. Am J Roentgenol. 2022;218:624–32.CrossRef
11.
Zurück zum Zitat Nakayama S, Kobayashi E, Nishio J, Toda Y, Yotsukura M, Watanabe S-I, et al. Prognostic factors of pulmonary metastasectomy for soft tissue sarcomas arising in the trunk wall and extremities. Cancers. 2022;14:3329.PubMedPubMedCentralCrossRef Nakayama S, Kobayashi E, Nishio J, Toda Y, Yotsukura M, Watanabe S-I, et al. Prognostic factors of pulmonary metastasectomy for soft tissue sarcomas arising in the trunk wall and extremities. Cancers. 2022;14:3329.PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Treasure T, Farewell V, Macbeth F, Monson K, Williams NR, Brew-Graves C, et al. Pulmonary metastasectomy versus continued active monitoring in colorectal cancer (PulMiCC): a multicentre randomised clinical trial. Trials. 2019;20:718.PubMedPubMedCentralCrossRef Treasure T, Farewell V, Macbeth F, Monson K, Williams NR, Brew-Graves C, et al. Pulmonary metastasectomy versus continued active monitoring in colorectal cancer (PulMiCC): a multicentre randomised clinical trial. Trials. 2019;20:718.PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Treasure T, Macbeth F. Doubt about effectiveness of lung metastasectomy for sarcoma. J Thorac Cardiovasc Surg. 2015;149:93–4.PubMedCrossRef Treasure T, Macbeth F. Doubt about effectiveness of lung metastasectomy for sarcoma. J Thorac Cardiovasc Surg. 2015;149:93–4.PubMedCrossRef
14.
Zurück zum Zitat Choi JH, Ro JY. The 2020 WHO classification of tumors of soft tissue: selected changes and new entities. Adv Anat Pathol. 2021;28:44–58.PubMedCrossRef Choi JH, Ro JY. The 2020 WHO classification of tumors of soft tissue: selected changes and new entities. Adv Anat Pathol. 2021;28:44–58.PubMedCrossRef
15.
Zurück zum Zitat Yamamoto H, Namba K, Yamamoto H, Toji T, Soh J, Shien K, et al. The neutrophil-to-lymphocyte ratio as a novel independent prognostic factor for multiple metastatic lung tumors from various sarcomas. Surg Today. 2021;51:127–35.PubMedCrossRef Yamamoto H, Namba K, Yamamoto H, Toji T, Soh J, Shien K, et al. The neutrophil-to-lymphocyte ratio as a novel independent prognostic factor for multiple metastatic lung tumors from various sarcomas. Surg Today. 2021;51:127–35.PubMedCrossRef
17.
Zurück zum Zitat Cheung F, Alam N, Wright G. Pulmonary metastasectomy: analysis of survival and prognostic factors in 243 patients. ANZ J Surg. 2018;88:1316–21.PubMedCrossRef Cheung F, Alam N, Wright G. Pulmonary metastasectomy: analysis of survival and prognostic factors in 243 patients. ANZ J Surg. 2018;88:1316–21.PubMedCrossRef
18.
Zurück zum Zitat Gusho CA, Seder CW, Lopez-Hisijos N, Blank AT, Batus M. Pulmonary metastasectomy in bone and soft tissue sarcoma with metastasis to the lung. Interact Cardiovasc Thorac Surg. 2021;33:879–84.PubMedPubMedCentralCrossRef Gusho CA, Seder CW, Lopez-Hisijos N, Blank AT, Batus M. Pulmonary metastasectomy in bone and soft tissue sarcoma with metastasis to the lung. Interact Cardiovasc Thorac Surg. 2021;33:879–84.PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Lin AY, Kotova S, Yanagawa J, Elbuluk O, Wang G, Kar N, et al. Risk stratification of patients undergoing pulmonary metastasectomy for soft tissue and bone sarcomas. J Thorac Cardiovasc Surg. 2015;149:85–92.PubMedCrossRef Lin AY, Kotova S, Yanagawa J, Elbuluk O, Wang G, Kar N, et al. Risk stratification of patients undergoing pulmonary metastasectomy for soft tissue and bone sarcomas. J Thorac Cardiovasc Surg. 2015;149:85–92.PubMedCrossRef
20.
Zurück zum Zitat Salah S, Fayoumi S, Alibraheem A, Massad E, Abdel Jalil R, Yaser S, et al. The influence of pulmonary metastasectomy on survival in osteosarcoma and soft-tissue sarcomas: a retrospective analysis of survival outcomes, hospitalizations and requirements of home oxygen therapy. Interact Cardiovasc Thorac Surg. 2013;17:296–302.PubMedPubMedCentralCrossRef Salah S, Fayoumi S, Alibraheem A, Massad E, Abdel Jalil R, Yaser S, et al. The influence of pulmonary metastasectomy on survival in osteosarcoma and soft-tissue sarcomas: a retrospective analysis of survival outcomes, hospitalizations and requirements of home oxygen therapy. Interact Cardiovasc Thorac Surg. 2013;17:296–302.PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Lautz TB, Farooqui Z, Jenkins T, Heaton TE, Doski JJ, Cooke-Barber J, et al. Thoracoscopy vs thoracotomy for the management of metastatic osteosarcoma: a pediatric surgical oncology research collaborative study. Int J Cancer. 2021;148:1164–71.PubMedCrossRef Lautz TB, Farooqui Z, Jenkins T, Heaton TE, Doski JJ, Cooke-Barber J, et al. Thoracoscopy vs thoracotomy for the management of metastatic osteosarcoma: a pediatric surgical oncology research collaborative study. Int J Cancer. 2021;148:1164–71.PubMedCrossRef
22.
Zurück zum Zitat Chudgar NP, Brennan MF, Tan KS, Munhoz RR, D’Angelo SP, Bains MS, et al. Is repeat pulmonary metastasectomy indicated for soft tissue sarcoma? Ann Thorac Surg. 2017;104:1837–45.PubMedPubMedCentralCrossRef Chudgar NP, Brennan MF, Tan KS, Munhoz RR, D’Angelo SP, Bains MS, et al. Is repeat pulmonary metastasectomy indicated for soft tissue sarcoma? Ann Thorac Surg. 2017;104:1837–45.PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Stanelle EJ, Christison-Lagay ER, Wolden SL, Meyers PA, Quaglia MPL. Pulmonary metastasectomy in pediatric/adolescent patients with synovial sarcoma: An institutional review. J Pediatr Surg. 2013;48:757–63.PubMedCrossRef Stanelle EJ, Christison-Lagay ER, Wolden SL, Meyers PA, Quaglia MPL. Pulmonary metastasectomy in pediatric/adolescent patients with synovial sarcoma: An institutional review. J Pediatr Surg. 2013;48:757–63.PubMedCrossRef
24.
Zurück zum Zitat Tetta C, Rocca M, Salone M, Longhi A, Ferrari C, Londero F, et al. Predictors of lung recurrence and disease-specific mortality after pulmonary metastasectomy for soft tissue sarcoma. Surg Oncol. 2021;37: 101532.PubMedCrossRef Tetta C, Rocca M, Salone M, Longhi A, Ferrari C, Londero F, et al. Predictors of lung recurrence and disease-specific mortality after pulmonary metastasectomy for soft tissue sarcoma. Surg Oncol. 2021;37: 101532.PubMedCrossRef
25.
Zurück zum Zitat Sambri A, Rocca M, Tuzzato G, Donati DM, Bianchi G. Lung Metastasectomy improves survival in patients affected by grade 2 and 3 chondrosarcoma. Oncol Res Treat. 2020;43:134–9.PubMedCrossRef Sambri A, Rocca M, Tuzzato G, Donati DM, Bianchi G. Lung Metastasectomy improves survival in patients affected by grade 2 and 3 chondrosarcoma. Oncol Res Treat. 2020;43:134–9.PubMedCrossRef
26.
Zurück zum Zitat Kim S, Ott HC, Wright CD, Wain JC, Morse C, Gaissert HA, et al. Pulmonary resection of metastatic sarcoma: prognostic factors associated with improved outcomes. Ann Thorac Surg. 2011;92:1780–7.PubMedCrossRef Kim S, Ott HC, Wright CD, Wain JC, Morse C, Gaissert HA, et al. Pulmonary resection of metastatic sarcoma: prognostic factors associated with improved outcomes. Ann Thorac Surg. 2011;92:1780–7.PubMedCrossRef
27.
Zurück zum Zitat Okiror L, Peleki A, Moffat D, Bille A, Bishay E, Rajesh P, et al. Survival following pulmonary metastasectomy for sarcoma. Thorac Cardiovasc Surg. 2016;64:146–9.PubMedCrossRef Okiror L, Peleki A, Moffat D, Bille A, Bishay E, Rajesh P, et al. Survival following pulmonary metastasectomy for sarcoma. Thorac Cardiovasc Surg. 2016;64:146–9.PubMedCrossRef
28.
Zurück zum Zitat Matsumoto I, Oda M, Yachi T, Tsuchiya H, Zen Y, Watanabe G. Outcome prediction of pulmonary metastasectomy can be evaluated using metastatic lesion in osteosarcoma patients. World J Surg. 2013;37:1973–80.PubMedCrossRef Matsumoto I, Oda M, Yachi T, Tsuchiya H, Zen Y, Watanabe G. Outcome prediction of pulmonary metastasectomy can be evaluated using metastatic lesion in osteosarcoma patients. World J Surg. 2013;37:1973–80.PubMedCrossRef
29.
Zurück zum Zitat Dossett LA, Toloza EM, Fontaine J, Robinson LA, Reed D, Druta M, et al. Outcomes and clinical predictors of improved survival in a patients undergoing pulmonary metastasectomy for sarcoma. J Surg Oncol. 2015;112:103–6.PubMedCrossRef Dossett LA, Toloza EM, Fontaine J, Robinson LA, Reed D, Druta M, et al. Outcomes and clinical predictors of improved survival in a patients undergoing pulmonary metastasectomy for sarcoma. J Surg Oncol. 2015;112:103–6.PubMedCrossRef
30.
Zurück zum Zitat Nakamura T, Matsumine A, Takao M, Nakatsuka A, Matsubara T, Asanuma K, et al. Impact of tumor volume doubling time on post-metastatic survival in bone or soft-tissue sarcoma patients treated with metastasectomy and/or radiofrequency ablation of the lung. OncoTargets Ther. 2017;10:559–64.CrossRef Nakamura T, Matsumine A, Takao M, Nakatsuka A, Matsubara T, Asanuma K, et al. Impact of tumor volume doubling time on post-metastatic survival in bone or soft-tissue sarcoma patients treated with metastasectomy and/or radiofrequency ablation of the lung. OncoTargets Ther. 2017;10:559–64.CrossRef
31.
Zurück zum Zitat Toussi MS, Bagheri R, Dayani M, Anvari K, Sheibani S. Pulmonary metastasectomy and repeat metastasectomy for soft-tissue sarcoma. Asian Cardiovasc Thorac Ann. 2013;21:437–42.PubMedCrossRef Toussi MS, Bagheri R, Dayani M, Anvari K, Sheibani S. Pulmonary metastasectomy and repeat metastasectomy for soft-tissue sarcoma. Asian Cardiovasc Thorac Ann. 2013;21:437–42.PubMedCrossRef
32.
Zurück zum Zitat Ohnstad HO, Bruland ØS, Taksdal I, Bjerkehagen B, Nenadovic M, Sæter G, et al. Response to preoperative chemotherapy in patients undergoing resection of pulmonary metastasis from soft tissue sarcoma – a predictor of outcome? Acta Oncol. 2014;53:1180–7.PubMedCrossRef Ohnstad HO, Bruland ØS, Taksdal I, Bjerkehagen B, Nenadovic M, Sæter G, et al. Response to preoperative chemotherapy in patients undergoing resection of pulmonary metastasis from soft tissue sarcoma – a predictor of outcome? Acta Oncol. 2014;53:1180–7.PubMedCrossRef
33.
Zurück zum Zitat Heaton TE, Hammond WJ, Farber BA, Pallos V, Meyers PA, Chou AJ, et al. A 20-year retrospective analysis of CT-based pre-operative identification of pulmonary metastases in patients with osteosarcoma: A single-center review. J Pediatr Surg. 2017;52:115–9.PubMedCrossRef Heaton TE, Hammond WJ, Farber BA, Pallos V, Meyers PA, Chou AJ, et al. A 20-year retrospective analysis of CT-based pre-operative identification of pulmonary metastases in patients with osteosarcoma: A single-center review. J Pediatr Surg. 2017;52:115–9.PubMedCrossRef
34.
Zurück zum Zitat Ahmed G, Elshafiey M, Romeih M, Elgammal A, Kamel A, Salama A, et al. Prognostic significance of the ratio of surgically resected to radiologically detected lung nodules in patients with metastatic osteosarcoma. Surg Oncol. 2022;40: 101701.PubMedCrossRef Ahmed G, Elshafiey M, Romeih M, Elgammal A, Kamel A, Salama A, et al. Prognostic significance of the ratio of surgically resected to radiologically detected lung nodules in patients with metastatic osteosarcoma. Surg Oncol. 2022;40: 101701.PubMedCrossRef
35.
Zurück zum Zitat Pfannschmidt J, Klode J, Muley T, Dienemann H, Hoffmann H. Nodal involvement at the time of pulmonary metastasectomy: experiences in 245 patients. Ann Thorac Surg. 2006;81:448–54.PubMedCrossRef Pfannschmidt J, Klode J, Muley T, Dienemann H, Hoffmann H. Nodal involvement at the time of pulmonary metastasectomy: experiences in 245 patients. Ann Thorac Surg. 2006;81:448–54.PubMedCrossRef
36.
Zurück zum Zitat Krüger M, Schmitto JD, Wiegmann B, Rajab TK, Haverich A. Optimal timing of pulmonary metastasectomy – Is a delayed operation beneficial or counterproductive? Eur J Surg Oncol Elsevier. 2014;40:1049–55.CrossRef Krüger M, Schmitto JD, Wiegmann B, Rajab TK, Haverich A. Optimal timing of pulmonary metastasectomy – Is a delayed operation beneficial or counterproductive? Eur J Surg Oncol Elsevier. 2014;40:1049–55.CrossRef
37.
Zurück zum Zitat Dear RF, Kelly PJ, Wright GM, Stalley P, Mccaughan BC, Tattersall MH. Pulmonary metastasectomy for bone and soft tissue sarcoma in Australia: 114 patients from 1978 to 2008. Asia Pac J Clin Oncol. 2012;8:292–302.PubMedCrossRef Dear RF, Kelly PJ, Wright GM, Stalley P, Mccaughan BC, Tattersall MH. Pulmonary metastasectomy for bone and soft tissue sarcoma in Australia: 114 patients from 1978 to 2008. Asia Pac J Clin Oncol. 2012;8:292–302.PubMedCrossRef
38.
Zurück zum Zitat Ahmed G, Zamzam M, Kamel A, Ahmed S, Salama A, Zaki I, et al. Effect of timing of pulmonary metastasis occurrence on the outcome of metastasectomy in osteosarcoma patients. J Pediatr Surg. 2019;54:775–9.PubMedCrossRef Ahmed G, Zamzam M, Kamel A, Ahmed S, Salama A, Zaki I, et al. Effect of timing of pulmonary metastasis occurrence on the outcome of metastasectomy in osteosarcoma patients. J Pediatr Surg. 2019;54:775–9.PubMedCrossRef
39.
Zurück zum Zitat Stork T, Boemans R, Hardes J, Streitbürger A, Dirksen U, Pöttgen C, et al. Number of metastases and their response to chemotherapy impact survival of patients with isolated lung metastases from bone-derived sarcoma. BMC Cancer. 2021;21:375.PubMedPubMedCentralCrossRef Stork T, Boemans R, Hardes J, Streitbürger A, Dirksen U, Pöttgen C, et al. Number of metastases and their response to chemotherapy impact survival of patients with isolated lung metastases from bone-derived sarcoma. BMC Cancer. 2021;21:375.PubMedPubMedCentralCrossRef
40.
Zurück zum Zitat Stephens EH, Blackmon SH, Correa AM, Roth JA, Rice DC, Hofstetter W, et al. Progression after chemotherapy is a novel predictor of poor outcomes after pulmonary metastasectomy in sarcoma patients. J Am Coll Surg. 2011;212:821–6.PubMedCrossRef Stephens EH, Blackmon SH, Correa AM, Roth JA, Rice DC, Hofstetter W, et al. Progression after chemotherapy is a novel predictor of poor outcomes after pulmonary metastasectomy in sarcoma patients. J Am Coll Surg. 2011;212:821–6.PubMedCrossRef
41.
Zurück zum Zitat Chudgar NP, Brennan MF, Munhoz RR, Bucciarelli PR, Tan KS, D’Angelo SP, et al. Pulmonary metastasectomy with therapeutic intent for soft-tissue sarcoma. J Thorac Cardiovasc Surg. 2017;154:319-330.e1.PubMedPubMedCentralCrossRef Chudgar NP, Brennan MF, Munhoz RR, Bucciarelli PR, Tan KS, D’Angelo SP, et al. Pulmonary metastasectomy with therapeutic intent for soft-tissue sarcoma. J Thorac Cardiovasc Surg. 2017;154:319-330.e1.PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat García Franco CE, Torre W, Tamura A, Guillén-Grima F, San-Julian M, Martin-Algarra S, et al. Long-term results after resection for bone sarcoma pulmonary metastases. Eur J Cardiothorac Surg. 2010;37:1205–8.PubMedCrossRef García Franco CE, Torre W, Tamura A, Guillén-Grima F, San-Julian M, Martin-Algarra S, et al. Long-term results after resection for bone sarcoma pulmonary metastases. Eur J Cardiothorac Surg. 2010;37:1205–8.PubMedCrossRef
43.
Zurück zum Zitat Mizuno T, Taniguchi T, Ishikawa Y, Kawaguchi K, Fukui T, Ishiguro F, et al. Pulmonary metastasectomy for osteogenic and soft tissue sarcoma: who really benefits from surgical treatment? Eur J Cardiothorac Surg. 2013;43:795–9.PubMedCrossRef Mizuno T, Taniguchi T, Ishikawa Y, Kawaguchi K, Fukui T, Ishiguro F, et al. Pulmonary metastasectomy for osteogenic and soft tissue sarcoma: who really benefits from surgical treatment? Eur J Cardiothorac Surg. 2013;43:795–9.PubMedCrossRef
44.
Zurück zum Zitat Tanju S, Saricam M, Kaba E, Kapdagli M, Dilege S, Toker A. Factors associated with pulmonary recurrence after pulmonary metastasectomy for sarcomatous disease. Surg Today. 2014;44:914–8.PubMedCrossRef Tanju S, Saricam M, Kaba E, Kapdagli M, Dilege S, Toker A. Factors associated with pulmonary recurrence after pulmonary metastasectomy for sarcomatous disease. Surg Today. 2014;44:914–8.PubMedCrossRef
45.
Zurück zum Zitat Reza J, Sammann A, Jin C, Horvai A, Hudnall M, Jablons DM, et al. Aggressive and minimally invasive surgery for pulmonary metastasis of sarcoma. J Thorac Cardiovasc Surg. 2014;147:1193–201.PubMedCrossRef Reza J, Sammann A, Jin C, Horvai A, Hudnall M, Jablons DM, et al. Aggressive and minimally invasive surgery for pulmonary metastasis of sarcoma. J Thorac Cardiovasc Surg. 2014;147:1193–201.PubMedCrossRef
46.
Zurück zum Zitat Paramanathan A, Wright G. Pulmonary metastasectomy for sarcoma of gynaecologic origin. Heart Lung Circ. 2013;22:270–5.PubMedCrossRef Paramanathan A, Wright G. Pulmonary metastasectomy for sarcoma of gynaecologic origin. Heart Lung Circ. 2013;22:270–5.PubMedCrossRef
47.
Zurück zum Zitat Gossot D, Radu C, Girard P, Cesne AL, Bonvalot S, Boudaya MS, et al. Resection of pulmonary metastases from sarcoma: can some patients benefit from a less invasive approach? Ann Thorac Surg. 2009;87:238–43.PubMedCrossRef Gossot D, Radu C, Girard P, Cesne AL, Bonvalot S, Boudaya MS, et al. Resection of pulmonary metastases from sarcoma: can some patients benefit from a less invasive approach? Ann Thorac Surg. 2009;87:238–43.PubMedCrossRef
48.
Zurück zum Zitat Predina JD, Newton A, Deshpande C, Low P, Singhal S. Utilization of targeted near-infrared molecular imaging to improve pulmonary metastasectomy of osteosarcomas. J Biomed Opt. 2018;23:1.PubMedCrossRef Predina JD, Newton A, Deshpande C, Low P, Singhal S. Utilization of targeted near-infrared molecular imaging to improve pulmonary metastasectomy of osteosarcomas. J Biomed Opt. 2018;23:1.PubMedCrossRef
49.
Zurück zum Zitat Predina JD, Newton AD, Corbett C, Shin M, Sulfyok LF, Okusanya OT, et al. Near-infrared intraoperative imaging for minimally invasive pulmonary metastasectomy for sarcomas. J Thorac Cardiovasc Surg. 2019;157:2061–9.PubMedCrossRef Predina JD, Newton AD, Corbett C, Shin M, Sulfyok LF, Okusanya OT, et al. Near-infrared intraoperative imaging for minimally invasive pulmonary metastasectomy for sarcomas. J Thorac Cardiovasc Surg. 2019;157:2061–9.PubMedCrossRef
50.
Zurück zum Zitat Rijs Z, Shifai AN, Bosma SE, Kuppen PJK, Vahrmeijer AL, Keereweer S, et al. Candidate biomarkers for specific intraoperative near-infrared imaging of soft tissue sarcomas: a systematic review. Cancers. 2021;13:557.PubMedPubMedCentralCrossRef Rijs Z, Shifai AN, Bosma SE, Kuppen PJK, Vahrmeijer AL, Keereweer S, et al. Candidate biomarkers for specific intraoperative near-infrared imaging of soft tissue sarcomas: a systematic review. Cancers. 2021;13:557.PubMedPubMedCentralCrossRef
51.
Zurück zum Zitat Li Y, Zhang W, Li S, Tu C. Clinical efficiency of repeated pulmonary metastasectomy in sarcoma patients with recurrent pulmonary metastasis: A meta-analysis. J Cancer Res Ther. 2018;14:457.CrossRef Li Y, Zhang W, Li S, Tu C. Clinical efficiency of repeated pulmonary metastasectomy in sarcoma patients with recurrent pulmonary metastasis: A meta-analysis. J Cancer Res Ther. 2018;14:457.CrossRef
52.
Zurück zum Zitat Treasure T, Fiorentino F, Scarci M, Møller H, Utley M. Pulmonary metastasectomy for sarcoma: a systematic review of reported outcomes in the context of Thames Cancer Registry data. BMJ Open. 2012;2: e001736.PubMedPubMedCentralCrossRef Treasure T, Fiorentino F, Scarci M, Møller H, Utley M. Pulmonary metastasectomy for sarcoma: a systematic review of reported outcomes in the context of Thames Cancer Registry data. BMJ Open. 2012;2: e001736.PubMedPubMedCentralCrossRef
53.
Zurück zum Zitat Cariboni U, De Sanctis R, Giaretta M, Voulaz E, Morenghi E, Colombo P, et al. Survival outcome and prognostic factors after pulmonary metastasectomy in sarcoma patients: a 18-year experience at a single high-volume referral center. Am J Clin Oncol. 2019;42:6–11.PubMedCrossRef Cariboni U, De Sanctis R, Giaretta M, Voulaz E, Morenghi E, Colombo P, et al. Survival outcome and prognostic factors after pulmonary metastasectomy in sarcoma patients: a 18-year experience at a single high-volume referral center. Am J Clin Oncol. 2019;42:6–11.PubMedCrossRef
54.
Zurück zum Zitat Balduyck B, Thielen JV, Cogen A, Hengst WD, Hendriks J, Lauwers P, et al. Quality of life evolution after pulmonary metastasectomy: a prospective study comparing isolated lung perfusion with standard metastasectomy. J Thorac Oncol. 2012;7:1567–73.PubMedCrossRef Balduyck B, Thielen JV, Cogen A, Hengst WD, Hendriks J, Lauwers P, et al. Quality of life evolution after pulmonary metastasectomy: a prospective study comparing isolated lung perfusion with standard metastasectomy. J Thorac Oncol. 2012;7:1567–73.PubMedCrossRef
55.
Zurück zum Zitat da Silva Sardenberg RA, de Figueiredo LP, Haddad FJ, Luiz Gross J, Younes RN. Pulmonary metastasectomy from soft tissue sarcomas. Clinics. 2010;65:871–6.PubMedCentralCrossRef da Silva Sardenberg RA, de Figueiredo LP, Haddad FJ, Luiz Gross J, Younes RN. Pulmonary metastasectomy from soft tissue sarcomas. Clinics. 2010;65:871–6.PubMedCentralCrossRef
56.
Zurück zum Zitat Giuliano K, Sachs T, Montgomery E, Guzzetta A, Brock M, Pawlik TM, et al. Survival following lung metastasectomy in soft tissue sarcomas. Thorac Cardiovasc Surg. 2016;64:150–8.PubMedCrossRef Giuliano K, Sachs T, Montgomery E, Guzzetta A, Brock M, Pawlik TM, et al. Survival following lung metastasectomy in soft tissue sarcomas. Thorac Cardiovasc Surg. 2016;64:150–8.PubMedCrossRef
57.
Zurück zum Zitat Smith R, Pak Y, Kraybill W, Kane JM. Factors associated with actual long-term survival following soft tissue sarcoma pulmonary metastasectomy. Eur J Surg Oncol. 2009;35:356–61.PubMedCrossRef Smith R, Pak Y, Kraybill W, Kane JM. Factors associated with actual long-term survival following soft tissue sarcoma pulmonary metastasectomy. Eur J Surg Oncol. 2009;35:356–61.PubMedCrossRef
58.
Zurück zum Zitat Takatsu F, Yamamoto H, Tomioka Y, Tanaka S, Shien K, Suzawa K, et al. Survival and prognostic factors in patients undergoing pulmonary metastasectomy for lung metastases from retroperitoneal sarcoma. World J Surg Oncol. 2022;20:114.PubMedPubMedCentralCrossRef Takatsu F, Yamamoto H, Tomioka Y, Tanaka S, Shien K, Suzawa K, et al. Survival and prognostic factors in patients undergoing pulmonary metastasectomy for lung metastases from retroperitoneal sarcoma. World J Surg Oncol. 2022;20:114.PubMedPubMedCentralCrossRef
59.
Zurück zum Zitat Yamamoto Y, Kanzaki R, Kanou T, Ose N, Funaki S, Shintani Y, et al. Long-term outcomes and prognostic factors of pulmonary metastasectomy for osteosarcoma and soft tissue sarcoma. Int J Clin Oncol. 2019;24:863–70.PubMedCrossRef Yamamoto Y, Kanzaki R, Kanou T, Ose N, Funaki S, Shintani Y, et al. Long-term outcomes and prognostic factors of pulmonary metastasectomy for osteosarcoma and soft tissue sarcoma. Int J Clin Oncol. 2019;24:863–70.PubMedCrossRef
Metadaten
Titel
Improving survival after pulmonary metastasectomy for sarcoma: analysis of prognostic factors
verfasst von
Daniel Shell
Publikationsdatum
12.01.2023
Verlag
Springer Nature Singapore
Erschienen in
General Thoracic and Cardiovascular Surgery / Ausgabe 5/2023
Print ISSN: 1863-6705
Elektronische ISSN: 1863-6713
DOI
https://doi.org/10.1007/s11748-023-01905-y

Weitere Artikel der Ausgabe 5/2023

General Thoracic and Cardiovascular Surgery 5/2023 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.